Merrifield C Ann

Merrifield C Ann is listed in filings as Director at Lyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 16, 2025, including 2 public disclosures. Recent filings connect the profile to Lyra Therapeutics, Inc. (LYRA). The current snapshot covers public activity from Jun 14, 2024 to May 16, 2025. Reported amounts are shown as $9.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.